NewGenIvf Group Limited (NASDAQ:NIVF – Get Free Report) Director Kong Yiu Cheung bought 500,000 shares of the company’s stock in a transaction on Thursday, June 18th. The stock was bought at an average cost of $1.33 per share, for a total transaction of $665,000.00. Following the completion of the acquisition, the director directly owned 1,222,223 shares of the company’s stock, valued at approximately $1,625,556.59. This represents a 69.23% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Kong Yiu Cheung also recently made the following trade(s):
- On Monday, July 27th, Kong Yiu Cheung bought 2,500,000 shares of NewGenIvf Group stock. The stock was bought at an average cost of $1.00 per share, for a total transaction of $2,500,000.00.
NewGenIvf Group Price Performance
Shares of NASDAQ:NIVF opened at $1.18 on Friday. The business has a fifty day moving average price of $2.79 and a 200-day moving average price of $10.97. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.98 and a current ratio of 3.12. NewGenIvf Group Limited has a 1-year low of $1.11 and a 1-year high of $1,539.00.
Analyst Ratings Changes
Read Our Latest Analysis on NIVF
About NewGenIvf Group
NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.
NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.
Featured Stories
- Five stocks we like better than NewGenIvf Group
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.
